- Patent Title: Predicting outcome of treatment with an anti-α4β7 integrin antibody
-
Application No.: US16455103Application Date: 2019-06-27
-
Publication No.: US11596688B2Publication Date: 2023-03-07
- Inventor: Maria Rosario , Timothy L. Wyant , Brihad Abhyankar
- Applicant: Millennium Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Millennium Pharmaceuticals, Inc.
- Current Assignee: Millennium Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Womble Bond Dickinson (US) LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; G01N33/53 ; G01N33/68 ; C07K16/28
Abstract:
The invention provides methods for treating patients with anti-α4β7 antibody comprising predicting outcome of the antibody therapy. The invention relates to the identification of patients who can respond to therapy comprising an anti-α4β7 antibody.
Public/Granted literature
- US20200155673A1 PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN ANTIBODY Public/Granted day:2020-05-21
Information query
